3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
4
Breast Neoplasms
3
Melanoma
2
Colorectal Neoplasms
2
Untreated Resectable Pancreatic Adenocarcinoma
1
Resectable Localized Prostate Cancer
1
Prostatic Neoplasms
1
Prostate Cancer Recurrent
1
Pancreatic Ductal Adenocarcinoma
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neoplasms
1
Neoplasm, Residual
1
Liver Neoplasms
1
Klatskin Tumor
1
Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer
1
Glioma
1
Gastrointestinal Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Adenocarcinoma
1
Interventions
Specimen Handling
9
Practice Guidelines as Topic
7
Standard of Care
6
Taxes
4
Paclitaxel
4
Early Intervention, Educational
4
Docetaxel
4
pertuzumab
3
Trastuzumab
3
Methods
3
Educational Status
3
trastuzumab biosimilar HLX02
2
pembrolizumab
2
PF-05280014
2
Ontruzant
2
Ogivri
2
Minoxidil
2
Magnetic Resonance Spectroscopy
2
Interviews as Topic
2
High-Energy Shock Waves
2
Cyclophosphamide
2
Carboplatin
2
Biopsy
2
2C4 antibody
2
regadenoson
1
nilotinib
1
fisetin
1
abemaciclib
1
Yoga
1
X-Ray Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anatomic Stage I Breast Cancer AJCC v8
×
Hydroxychloroquine
×
1 year
×
Clear all
No trials found.